Pre-configured to identify normal, high-vibration, and unstable motor conditions STMicroelectronics (NYSE:STM)GENEVA, ...
V GaN-based inverter reference design delivering 50 ARMS phase current, integrated sensing, and PWM operation up to ...
Abstract: Dual three-phase PMSM sensorless drive systems become attractive solutions for more electric aircraft applications due to their high-power density and potential fault tolerance capabilities.
Early GO decision reached in CAPTIVATE ahead of Q2’26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants completing open-label Part A ...
New Phase 1b data support the safety and effectiveness of salanersen over one year in children with SMA who had the potential for improvement due to suboptimal clinical status with prior gene ...
YouTube on MSN
New Challenger: Sudokoo Mach 120 Takes on Noctua’s Best
Today we’re taking a look at the Sudokoo Mach 120, a new fan aiming to challenge the Phanteks D30 and Noctua A12x25 G2, two of the top 120mm models on the market. We’ll be testing airflow, noise, and ...
Carlo Gavazzi is introducing the new EM630 B and EM640 B Series, the first models of the new EM600 Series of three-phase ...
Early GO decision reached ahead of Q2’26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants completing open-label Part A ...
The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed by Pfizer and BioNTech, which may offer quicker production and greater efficacy than shots ...
Company launched TONMYA, approved by the FDA as a treatment for fibromyalgia, in November 2025 In post hoc analysis of the pivotal RESILIENT study, TONMYA produced rapid pain relief as early as Day 2 ...
Summary CPEC Phase II marks a transition from infrastructure connectivity to industrial embeddedness, through which China could acquire longer-term influence over Pakistan’s manufacturing base, ...
Early GO decision reached ahead of Q2'26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants completing open-label Part A Key objectives achieved: ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果